Cite

HARVARD Citation

    Ray, S. et al. (2012). Current understanding of LRRK2 in Parkinson's disease: biochemical and structural features and inhibitor design. Future medicinal chemistry. pp. 1701-1713. [Online]. 
  
Back to record